Martijn L. Dijkstra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Martijn L. Dijkstra has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Rodney James Lane
Dalcross Private Hospital, Sydney, New South Wales, Australia
4 shared publications Walid Mohabbat
3 shared publicationsClark J. Zeebregts
The Division of Vascular Surgery, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
2 shared publicationsJan-Willem Lardenoye
Department of Surgery, Rijnstate Hospital, Arnhem, the Netherlands
2 shared publicationsAdam H. Power
The Division of Vascular Surgery, Western University, London, Ontario, Canada
1 shared publication- Clark J. Zeebregts
Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 March 2020
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 71 (3) , 780-789
Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data
- 1 March 2020
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 71 (3) , 780-789
Open AccessIncidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data
- 9 July 2016
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 23 (4) , 574-582
One-Year Outcomes of Endovascular Aneurysm Repair in High-Risk Patients Using the Endurant Stent-Graft
Purpose: To evaluate the outcome and survival of patients with extensive comorbid conditions after endovascular aneurysm repair (EVAR) and objectify which of 2 medical comorbidity classifications is more accurate in predicting adverse outcomes. Methods: All 1263 patients (mean age 73.1 years; 1129 men) treated using the Endurant Stent Graft system and entered in the prospective global postmarketing ENGAGE registry (ClinicalTrials.gov identifier NCT00870051) were grouped using the American Society of Anesthesiologists (ASA) classification and the Society for Vascular Surgery/American Association for Vascular Surgery (SVS/AAVS) medical comorbidity grading system. Patients assigned to ASA III and IV and SVS/AAVS 2 and 3 categories were considered high risk. Primary outcome was 1-year all-cause mortality. Secondary outcomes included technical and clinical success, major adverse events (MAE), aneurysm rupture, endoleaks, and secondary endovascular procedures. One-year follow-up of the entire ENGAGE cohort was the endpoint of the study. Results: A total of 1263 patients were included. The overall technical success rate was high, the lowest being 97.4% in the ASA I group. The overall 30-day and 1-year Kaplan-Meier survival estimates were 98.7% and 92.5%, respectively. All cause 1-year mortality was higher in the ASA III and IV groups, but this did not reach statistical significance (5.2% and 5.7% for ASA I and II vs 9.0% and 9.9% for ASA III and IV, p=0.12). In the SVS/AAVS groups, 1-year all-cause mortality significantly increased with the SVS/AAVS score to 11.3% in the SVS/AAVS 3 group (p=0.002). There were significantly more MAEs in the SVS/AAVS 3 group at 1 year (p<0.001 for group 1 vs 3 and group 2 vs 3). Conclusion: Endovascular aneurysm repair has evolved, and high technical success and low mortality and morbidity can be achieved in high-risk patients. When treating high-risk patients, the perioperative risks should always be weighed against the expected gains. In contrast to the ASA classification, the SVS/AAVS medical comorbidity grading system is a useful tool to predict occurrence of MAEs and 1-year survival in patients undergoing EVAR.
- 9 July 2016
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 23 (4) , 574-582
One-Year Outcomes of Endovascular Aneurysm Repair in High-Risk Patients Using the Endurant Stent-Graft
Purpose: To evaluate the outcome and survival of patients with extensive comorbid conditions after endovascular aneurysm repair (EVAR) and objectify which of 2 medical comorbidity classifications is more accurate in predicting adverse outcomes. Methods: All 1263 patients (mean age 73.1 years; 1129 men) treated using the Endurant Stent Graft system and entered in the prospective global postmarketing ENGAGE registry (ClinicalTrials.gov identifier NCT00870051) were grouped using the American Society of Anesthesiologists (ASA) classification and the Society for Vascular Surgery/American Association for Vascular Surgery (SVS/AAVS) medical comorbidity grading system. Patients assigned to ASA III and IV and SVS/AAVS 2 and 3 categories were considered high risk. Primary outcome was 1-year all-cause mortality. Secondary outcomes included technical and clinical success, major adverse events (MAE), aneurysm rupture, endoleaks, and secondary endovascular procedures. One-year follow-up of the entire ENGAGE cohort was the endpoint of the study. Results: A total of 1263 patients were included. The overall technical success rate was high, the lowest being 97.4% in the ASA I group. The overall 30-day and 1-year Kaplan-Meier survival estimates were 98.7% and 92.5%, respectively. All cause 1-year mortality was higher in the ASA III and IV groups, but this did not reach statistical significance (5.2% and 5.7% for ASA I and II vs 9.0% and 9.9% for ASA III and IV, p=0.12). In the SVS/AAVS groups, 1-year all-cause mortality significantly increased with the SVS/AAVS score to 11.3% in the SVS/AAVS 3 group (p=0.002). There were significantly more MAEs in the SVS/AAVS 3 group at 1 year (p<0.001 for group 1 vs 3 and group 2 vs 3). Conclusion: Endovascular aneurysm repair has evolved, and high technical success and low mortality and morbidity can be achieved in high-risk patients. When treating high-risk patients, the perioperative risks should always be weighed against the expected gains. In contrast to the ASA classification, the SVS/AAVS medical comorbidity grading system is a useful tool to predict occurrence of MAEs and 1-year survival in patients undergoing EVAR.
- 1 August 2014
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 60 (2) , 301-307
Dutch experience with the fenestrated Anaconda endograft for short-neck infrarenal and juxtarenal abdominal aortic aneurysm repair
- 1 August 2014
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 60 (2) , 301-307
Dutch experience with the fenestrated Anaconda endograft for short-neck infrarenal and juxtarenal abdominal aortic aneurysm repair
- 1 April 2013
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 1 (2) , 181-186
Popliteal vein compression syndrome pathophysiology and correlation with popliteal compartment pressures
- 1 April 2013
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 1 (2) , 181-186
Popliteal vein compression syndrome pathophysiology and correlation with popliteal compartment pressures
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 53S-54S
PS104. Hypertensive Extracorporeal Limb Perfusion (HELP)
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 53S-54S
PS104. Hypertensive Extracorporeal Limb Perfusion (HELP)
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 61S
PS134. Endovenous Valve Transfer for Chronic Venous Hypertension
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 61S
PS134. Endovenous Valve Transfer for Chronic Venous Hypertension
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 61S-62S
PS136. Effect of Pregnancy on Exostent Venous Valve Repair at the Sapheno Femoral Junction (SFJ)
- 1 June 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (6) , 61S-62S
PS136. Effect of Pregnancy on Exostent Venous Valve Repair at the Sapheno Femoral Junction (SFJ)